Inovio (INO) Pharmaceuticals announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares of common stock in the proposed offering will be sold by Inovio. Piper Sandler & Co. is acting as sole book-running manager for the offering.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INO:
- Inovio reports Q3 EPS (87c), consensus (48c)
- Options Volatility and Implied Earnings Moves Today, November 10, 2025
- Options Volatility and Implied Earnings Moves This Week, November 10 – November 14, 2025
- Is INO a Buy, Before Earnings?
- Inovio Pharmaceuticals: Hold Rating Amid Promising Developments and Significant Risks